The European Medicines Agency (EMA) approves extention of shelf life for Strangvac, a vaccine against equine strangles, to 33 months
Stockholm, May 17th, 2023 - The European Medicines Agency (EMA) has, after reviewing stability data, approved the extension of the shelf life for Strangvac, to 33 months from previously 24 months. The Veterinary Medicines Directorate (VMD) the authority responsible for veterinary medicines in the UK, has previously approved the extension of the shelf life for Strangvac. “It is positive that the European Medicines Agency (EMA) now has approved a 33-month shelf life for Strangvac. It provides us with increased flexibility in the logistics chain and facilitates planning of production”,